Deleted Tweets From Scott Gottlieb, R-D.C.

In January a congressionally-mandated report from the National Academies of Sciences, Engineering & Medicine (NASEM) found “substantial evidence” that kids who use e-cigarettes are more likely to try combustible cigarettes https://t.co/IptCuwMTRO. https://t.co/FNna6DzwPY

#FDA recognizes that there is some evidence that e-cigs may represent an important opportunity for adult smokers to transition off combustible tobacco products and onto nicotine delivery products that may not have the same level of risks associated with them.

NASEM’s report was based on a review of 800 peer-reviewed articles. The committee found emerging evidence to suggest that vaping may be harmful to the lungs and said more research is needed to understand the long-term consequences of using these products. https://t.co/Ae7bgl3Suq

And while e-cigs may be less harmful than combustible tobacco, the notion of relative risk only is relevant to considering how to help current cigarette smokers. The “harm reduction” debate does not countenance kids using these products. No kids should be using tobacco products.

But the FDA won’t tolerate a whole generation of young people becoming addicted to nicotine as a tradeoff for enabling adults to have unfettered access to these same products.

This summer we issued more than 1,300 warning letters and fines to retailers who illegally sold e-cig products to minors. This nationwide undercover blitz of brick and mortar and online stores was the largest coordinated enforcement effort in #FDA history https://t.co/pnJmRbYBW0. https://t.co/VWW06RnrWU

FDA is also exploring clear & meaningful measures to make tobacco products less toxic, appealing & addictive, which could include examining flavors/designs that appeal to youth, child-resistant packaging & product labeling to prevent accidental child exposure to liquid nicotine.

In partnership with the @FTC, we’ve targeted misleadingly labeled or advertised e-liquids resembling kid-friendly foods like juice boxes, candy and cookies. Other retailers that have continued to advertise & sell these products have received warnings – 12 went out Sept. 12. https://t.co/QThbr9buaE

Research shows that about 80% of youth do not see great risk of harm from regular use of e-cigarettes, highlighting the need for a targeted education effort focused on the potential dangers of e-cig use in adolescence https://t.co/bDFcBEm2fm. https://t.co/hEoLPC0QIl

We told five major e-cig manufacturers to submit plans within 60 days for addressing and mitigating these trends or #FDA will reconsider extending the compliance dates for submission of premarket applications for certain flavored e-cigs https://t.co/CzHzkDpdlK.

So last week FDA launched “The Real Cost” E-cigarette Prevention Campaign designed to snap teens out of their “cost-free” mentality by educating them about the potential risks of these products, urging them to “know the real cost of vaping.” https://t.co/8Q6xuB8OyA

It’s the latest of FDA’s “The Real Cost” teen campaigns. The 1st one, on smoking, has been highly effective. From 2014-2015, it prevented an estimated 350,000 teens from initiating smoking. Half might have gone on to become established adult smokers https://t.co/ZjNcVPqd1X. https://t.co/wQAuO3uqP2

We don’t want our campaign to discourage adults from using e-cigs to help transition away from cigarettes, so “The Real Cost” e-cig ads will run on age-verified digital platforms and in high schools to minimize the number of adults who view the ads.

FDA’s “The Real Cost” campaign has also saved $31+ billion by reducing smoking-related costs like early loss of life, costly medical care, lost wages, lower productivity and increased disability. https://t.co/6niq6hfMoH https://t.co/kW9AW7VtEB

Going forward, we’re committed to the development of guidance and regulations to better spell out how premarket applications can show that the marketing of the product is appropriate for the protection of the health of the overall population.

We're also closely examining whether some e-cig products may be on the market unlawfully. We will have much more to say about that shortly. Among the actions we may announce; it could include notifications that we send to manufacturers, targeted inspections, and other steps.

Smoking is the #1 preventable cause of death in America. It kills about 500,000 people a year. If we can't more sharply reduce the rate of addiction to tobacco, we’ll continue to see needless death and disease. We won't allow a new generation of kids to get addicted to nicotine. https://t.co/bjkIOoJr20

RT @NatureNews: US Food and Drug Administration proposes stiff fines for failing to report clinical trials. https://t.co/xDSAsyKgl8

That’s tens of billions of dollars in savings available to American patients and consumers. The #FDA's increasingly efficient, effective generic drug program - supported by its outstanding team - has helped maintain that balance.

... 2/2 In other words, Americans generally paid less at home than if they bought these same drugs abroad. Purchasing these generics at Swiss prices would have been $19.3 billion more expensive, while buying these same generic drugs in Canada would have cost $12.1 billion more.

In January a congressionally-mandated report from the National Academies of Sciences, Engineering & Medicine (NASEM) found “substantial evidence” that kids who use e-cigarettes are more likely to try combustible cigarettes https://t.co/IptCuwMTRO. https://t.co/FNna6DzwPY

#FDA recognizes that there is some evidence that e-cigs may represent an important opportunity for adult smokers to transition off combustible tobacco products and onto nicotine delivery products that may not have the same level of risks associated with them.

NASEM’s report was based on a review of 800 peer-reviewed articles. The committee found emerging evidence to suggest that vaping may be harmful to the lungs and said more research is needed to understand the long-term consequences of using these products. https://t.co/Ae7bgl3Suq

And while e-cigs may be less harmful than combustible tobacco, the notion of relative risk only is relevant to considering how to help current cigarette smokers. The “harm reduction” debate does not countenance kids using these products. No kids should be using tobacco products.

But the FDA won’t tolerate a whole generation of young people becoming addicted to nicotine as a tradeoff for enabling adults to have unfettered access to these same products.

This summer we issued more than 1,300 warning letters and fines to retailers who illegally sold e-cig products to minors. This nationwide undercover blitz of brick and mortar and online stores was the largest coordinated enforcement effort in #FDA history https://t.co/pnJmRbYBW0. https://t.co/VWW06RnrWU

FDA is also exploring clear & meaningful measures to make tobacco products less toxic, appealing & addictive, which could include examining flavors/designs that appeal to youth, child-resistant packaging & product labeling to prevent accidental child exposure to liquid nicotine.

In partnership with the @FTC, we’ve targeted misleadingly labeled or advertised e-liquids resembling kid-friendly foods like juice boxes, candy and cookies. Other retailers that have continued to advertise & sell these products have received warnings – 12 went out Sept. 12. https://t.co/QThbr9buaE

Research shows that about 80% of youth do not see great risk of harm from regular use of e-cigarettes, highlighting the need for a targeted education effort focused on the potential dangers of e-cig use in adolescence https://t.co/bDFcBEm2fm. https://t.co/hEoLPC0QIl

We told five major e-cig manufacturers to submit plans within 60 days for addressing and mitigating these trends or #FDA will reconsider extending the compliance dates for submission of premarket applications for certain flavored e-cigs https://t.co/CzHzkDpdlK.

So last week FDA launched “The Real Cost” E-cigarette Prevention Campaign designed to snap teens out of their “cost-free” mentality by educating them about the potential risks of these products, urging them to “know the real cost of vaping.” https://t.co/8Q6xuB8OyA

It’s the latest of FDA’s “The Real Cost” teen campaigns. The 1st one, on smoking, has been highly effective. From 2014-2015, it prevented an estimated 350,000 teens from initiating smoking. Half might have gone on to become established adult smokers https://t.co/ZjNcVPqd1X. https://t.co/wQAuO3uqP2

We don’t want our campaign to discourage adults from using e-cigs to help transition away from cigarettes, so “The Real Cost” e-cig ads will run on age-verified digital platforms and in high schools to minimize the number of adults who view the ads.

FDA’s “The Real Cost” campaign has also saved $31+ billion by reducing smoking-related costs like early loss of life, costly medical care, lost wages, lower productivity and increased disability. https://t.co/6niq6hfMoH https://t.co/kW9AW7VtEB

Going forward, we’re committed to the development of guidance and regulations to better spell out how premarket applications can show that the marketing of the product is appropriate for the protection of the health of the overall population.

We're also closely examining whether some e-cig products may be on the market unlawfully. We will have much more to say about that shortly. Among the actions we may announce; it could include notifications that we send to manufacturers, targeted inspections, and other steps.

Smoking is the #1 preventable cause of death in America. It kills about 500,000 people a year. If we can't more sharply reduce the rate of addiction to tobacco, we’ll continue to see needless death and disease. We won't allow a new generation of kids to get addicted to nicotine. https://t.co/bjkIOoJr20

RT @NatureNews: US Food and Drug Administration proposes stiff fines for failing to report clinical trials. https://t.co/xDSAsyKgl8

That’s tens of billions of dollars in savings available to American patients and consumers. The #FDA's increasingly efficient, effective generic drug program - supported by its outstanding team - has helped maintain that balance.

... 2/2 In other words, Americans generally paid less at home than if they bought these same drugs abroad. Purchasing these generics at Swiss prices would have been $19.3 billion more expensive, while buying these same generic drugs in Canada would have cost $12.1 billion more.